400-0755-639
联系微信客服
最新产品
三叶新科每月上新,持续为科研人员提供新颖性研究工具,助力科研创新与突破。
首页 最新产品
hCAIX-IN-18
目录号:SY-123528
hCAIX-IN-18 (compound 30) 作为一种碳酸酐酶抑制剂,对不同亚型碳酸酐酶的Ki值表现出得相应抑制效果,具体为hCAI的Ki值为3.5 nM,hCAII的Ki值为9.4 nM,hCAIX的Ki值为43.0 nM,以及hCAXII的Ki值为8.2 nM。
¥3887.00
查看详情
2-Cyclohexylethylamine Hydrochloride
目录号:SY-123529
2-Cyclohexylethylamine Hydrochloride对carbonic anhydrase具有抑制活性,可用于生物化学实验和药物合成研究。
¥92.00
查看详情
Dorzolamide
目录号:SY-123530
Dorzolamide is an anti-glaucoma agent and is a carbonic anhydrase inhibitor.
询价
查看详情
Bendroflumethiazide
目录号:SY-123531
Bendroflumethiazide (Naturetin) 是一种口服具有活性的利尿剂。它是一种抗高血压药。它对动脉高血压疾病具有潜在的研究价值。
¥760.00
查看详情
Quinethazone
目录号:SY-123532
Quinethazone is a thiazide diuretic used to treat hypertension. Common side effects include dizziness, dry mouth, nausea, and low potassium levels.
¥25070.00
查看详情
Ibuprofen acyl-β-D-glucuronide
目录号:SY-123533
布洛芬酰基-β-D-葡萄糖醛酸苷(Ibuprofen glucuronide)作为选择性TRPA1拮抗剂,能有效抑制AITC诱发的钙反应,显示出60μM的IC50值。
询价
查看详情
Dichlorphenamide-13C6
目录号:SY-123534
Dichlorphenamide-13C6 is intended for use as an internal standard for the quantification of dichlorphenamide by GC- or LC-MS. Dichlorphenamide (T6469) is a sulfonamide and an orally bioavailable carbonic anhydrase (CA)inhibitor (Kis = 1.20,38,50,and 50 nM for the human CA isoforms CAI,CAII,CAIX,and CAXII,respectively).1It lowers intraocular pressure in rabbits when 50 μl of a 10% solution is applied topically to the eye.2Dichlorphenamide rescues the potassium deficiency and prevents insulin-induced paralysis in a rat model of familial hypokalemic periodic paralysis when administered at a dose of 5.6 mg/kg per day for ten days.3Formulations containing dichlorphenamide have been used in the treatment of glaucoma and primary periodic paralysis.
询价
查看详情
Catechol diacetate
目录号:SY-123535
Catechol diacetate (Compound 15) 是碳酸酐酶 (CA) 抑制剂,具有在青光眼、癫痫、水肿及癌症研究中的应用潜力。
¥60.00
查看详情
hCAI/II/XII-IN-1
目录号:SY-123536
hCAII/XII/XIV-IN-1 是一种针对人类碳酸酐酶 hCAII、hCAXII 和 hCAXIV 的有效抑制剂,其对于hCAI/hCAII/hCAIX/hCAXII/hCAXIV的 Ki 值分别为 78.5 nM、9.1 nM、605 nM、7.7 nM 和 3.7 nM。
¥1495.00
查看详情